Skip to main content
TipRanks
Go Ultimate75% OFF

Esprinet Spa (0NFS) Share Price & Analysis

0 Followers

0NFS Stock Chart & Stats

€6.47-€0.57(-8.10%)
At close: 4:30 PM GMT
€6.5€7€7.5€8Aug 17Aug 31Sep 14Sep 29Oct 14Oct 30Nov 10
Day’s Range
EUR 6.47 - EUR 6.48
52-Week Range
EUR 4.50 - EUR 8.42
Previous Close
EUR 7.04
Volume
N/A
Average Volume (3M)
634
Market Cap
EUR 295.54M
Enterprise Value
EUR 827.59M
Total Cash (Recent Filing)
EUR 200.67M
Total Debt (Recent Filing)
EUR 494.41M
Price to Earnings (P/E)
13.8
Beta
0.21
Next Earnings
Mar 16, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
5.15%

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

The return to revenue growth indicates that Esprinet has regained some demand and channel traction after the 2023 downturn. Continued stabilization would support operating scale, strengthen its role with resellers and vendors, and provide a foundation for improving earnings over the next several quarters.

Broad Distribution Platform

A broad business-to-business channel gives Esprinet multiple routes to market for vendors and reduces reliance on a single customer type. Its combined sourcing, logistics, delivery, credit support and value-added services can remain relevant as technology products continue moving through indirect distribution.

Return To Profitability

The move from a 2023 loss back to modest profitability shows that the business can recover when revenue and operating conditions improve. Although returns remain limited, renewed earnings and positive equity returns improve internal funding capacity and provide a more stable base for future execution.

Bears Say

Negative Cash Generation

Negative operating and free cash flow is a material weakness because distribution businesses require liquidity to support inventory and customer working capital. The reversal from positive 2025 cash flow can constrain investment, increase reliance on financing, and make earnings less useful as a measure of financial strength.

Higher Leverage

The sharp increase in debt relative to equity reduces Esprinet’s financial flexibility and leaves less capacity to absorb working-capital swings or weaker margins. Combined with current cash burn, higher leverage can increase dependence on external funding and restrict future capital allocation choices.

Thin And Volatile Margins

Very thin profitability leaves limited protection against changes in pricing, product mix or shipment volumes, which are important drivers for a transaction-based distributor. The prior net loss also demonstrates earnings volatility, making sustained profit improvement harder to establish over the medium term.

Esprinet Spa News

0NFS FAQ

What was Esprinet Spa’s price range in the past 12 months?
Esprinet Spa lowest share price was €4.50 and its highest was €8.42 in the past 12 months.
What is Esprinet Spa’s market cap?
Esprinet Spa’s market cap is €295.54M.
When is Esprinet Spa’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Esprinet Spa’s earnings last quarter?
Esprinet Spa released its earnings results on Nov 11, 2026. The company reported €0.072 earnings per share for the quarter.
Is Esprinet Spa overvalued?
According to Wall Street analysts Esprinet Spa’s price is currently Undervalued.
Does Esprinet Spa pay dividends?
Esprinet Spa pays an annual dividend of €0.35 which represents an annual dividend yield of 5.15%. See more information on Esprinet Spa dividends here
What is Esprinet Spa’s EPS estimate?
Esprinet Spa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Esprinet Spa have?
Esprinet Spa has 50,417,416 shares outstanding.
What happened to Esprinet Spa’s price movement after its last earnings report?
Esprinet Spa reported an EPS of €0.072 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Esprinet Spa?
Currently, no hedge funds are holding shares in GB:0NFS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology